{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:04:06Z","timestamp":1775149446395,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13555-026-01717-x","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:58:45Z","timestamp":1772888325000},"page":"2181-2190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TROP-2 Is Not a Therapeutic Target in Melanoma: a Morphological Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Sonia","family":"Fantone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Molinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Goteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-0839","authenticated-orcid":false,"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tossetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"5","key":"1717_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/pcmr.13103","volume":"36","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Ceccarelli G, Fantone S, et al. Melanoma and subcutaneous adipose tissue: role of peritumoral adipokines in disease characterization and prognosis. Pigment Cell Melanoma Res. 2023;36(5):423\u201330. https:\/\/doi.org\/10.1111\/pcmr.13103.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1717_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040612","author":"M Emanuelli","year":"2022","unstructured":"Emanuelli M, Sartini D, Molinelli E, et al. The double-edged sword of oxidative stress in skin damage and melanoma: from physiopathology to therapeutical approaches. Antioxidants (Basel). 2022. https:\/\/doi.org\/10.3390\/antiox11040612.","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/CMR.0000000000000430","volume":"28","author":"G Ganzetti","year":"2018","unstructured":"Ganzetti G, Sartini D, Campanati A, et al. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma. Melanoma Res. 2018;28(2):82\u20138. https:\/\/doi.org\/10.1097\/CMR.0000000000000430.","journal-title":"Melanoma Res"},{"issue":"1","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s13577-022-00793-3","volume":"36","author":"D Sartini","year":"2023","unstructured":"Sartini D, Molinelli E, Pozzi V, et al. Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma. Hum Cell. 2023;36(1):480\u20132. https:\/\/doi.org\/10.1007\/s13577-022-00793-3.","journal-title":"Hum Cell"},{"key":"1717_CR5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17102-5","author":"MC Lowe","year":"2025","unstructured":"Lowe MC, Delman KA, Ollila DW. The landmark series: melanoma and adjuvant therapy. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17102-5.","journal-title":"Ann Surg Oncol"},{"key":"1717_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2025.2474182","author":"M Ferrari","year":"2025","unstructured":"Ferrari M, Facchini BA, Ascierto PA, et al. Melanoma neoadjuvant treatment: review and update of recent trials. Expert Rev Anticancer Ther. 2025. https:\/\/doi.org\/10.1080\/14737140.2025.2474182.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"1717_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70239","volume":"24","author":"A Basu","year":"2025","unstructured":"Basu A, Farsam V, Singh K, et al. Senescent fibroblasts drive melanoma progression through GCP-2 induced CREB phosphorylation enhancing glycolysis. Aging Cell. 2025;24(12):e70239. https:\/\/doi.org\/10.1111\/acel.70239.","journal-title":"Aging Cell"},{"key":"1717_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113328","author":"S Lenart","year":"2020","unstructured":"Lenart S, Lenart P, Smarda J, et al. Trop2: jack of all trades, master of none. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12113328.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1717_CR9","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1021\/acs.molpharmaceut.4c00848","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Huang W, Saladin RJ, et al. Trop2-targeted molecular imaging in solid tumors: current advances and future outlook. Mol Pharm. 2024;21(12):5909\u201328. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00848.","journal-title":"Mol Pharm"},{"key":"1717_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112441","volume":"191","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Wu Z. TROP2 promotes PINK1-mediated mitophagy and apoptosis to accelerate the progression of senile chronic obstructive pulmonary disease by up-regulating DRP1 expression. Exp Gerontol. 2024;191:112441. https:\/\/doi.org\/10.1016\/j.exger.2024.112441.","journal-title":"Exp Gerontol"},{"key":"1717_CR11","doi-asserted-by":"publisher","DOI":"10.1242\/bio.059403","author":"R Szabo","year":"2022","unstructured":"Szabo R, Ward JM, Artunc F, et al. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice. Biol Open. 2022. https:\/\/doi.org\/10.1242\/bio.059403.","journal-title":"Biol Open"},{"issue":"12","key":"1717_CR12","doi-asserted-by":"publisher","first-page":"e28607","DOI":"10.1371\/journal.pone.0028607","volume":"6","author":"Y Tsukahara","year":"2011","unstructured":"Tsukahara Y, Tanaka M, Miyajima A. TROP2 expressed in the trunk of the ureteric duct regulates branching morphogenesis during kidney development. PLoS ONE. 2011;6(12):e28607. https:\/\/doi.org\/10.1371\/journal.pone.0028607.","journal-title":"PLoS ONE"},{"issue":"9","key":"1717_CR13","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.7150\/thno.98178","volume":"14","author":"X Liu","year":"2024","unstructured":"Liu X, Ma L, Li J, et al. Trop2-targeted therapies in solid tumors: advances and future directions. Theranostics. 2024;14(9):3674\u201392. https:\/\/doi.org\/10.7150\/thno.98178.","journal-title":"Theranostics."},{"issue":"52","key":"1717_CR14","doi-asserted-by":"publisher","first-page":"20882","DOI":"10.1073\/pnas.0811411106","volume":"105","author":"AS Goldstein","year":"2008","unstructured":"Goldstein AS, Lawson DA, Cheng D, et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA. 2008;105(52):20882\u20137. https:\/\/doi.org\/10.1073\/pnas.0811411106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1717_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/pros.21083","volume":"70","author":"IP Garraway","year":"2010","unstructured":"Garraway IP, Sun W, Tran CP, et al. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010;70(5):491\u2013501. https:\/\/doi.org\/10.1002\/pros.21083.","journal-title":"Prostate"},{"issue":"7","key":"1717_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.21.7.2570-2580.2001","volume":"21","author":"M Balzar","year":"2001","unstructured":"Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol. 2001;21(7):2570\u201380. https:\/\/doi.org\/10.1128\/MCB.21.7.2570-2580.2001.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1717_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13577-025-01313-9","volume":"38","author":"G Tossetta","year":"2025","unstructured":"Tossetta G, Fantone S, Filosa A, et al. Psoriasis and lichen planus: an immunohistochemical study of trophoblast cell-surface antigen 2 expression in skin biopsies. Hum Cell. 2025;38(6):179. https:\/\/doi.org\/10.1007\/s13577-025-01313-9.","journal-title":"Hum Cell"},{"issue":"26","key":"1717_CR18","doi-asserted-by":"publisher","first-page":"22496","DOI":"10.18632\/oncotarget.4318","volume":"6","author":"DM Goldenberg","year":"2015","unstructured":"Goldenberg DM, Cardillo TM, Govindan SV, et al. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody\u2013drug conjugate (ADC). Oncotarget. 2015;6(26):22496\u2013512. https:\/\/doi.org\/10.18632\/oncotarget.4318.","journal-title":"Oncotarget"},{"issue":"5","key":"1717_CR19","doi-asserted-by":"publisher","first-page":"e12394","DOI":"10.1002\/2056-4538.12394","volume":"10","author":"S Foersch","year":"2024","unstructured":"Foersch S, Schmitt M, Litmeyer AS, et al. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis. J Pathol Clin Res. 2024;10(5):e12394. https:\/\/doi.org\/10.1002\/2056-4538.12394.","journal-title":"J Pathol Clin Res."},{"issue":"12","key":"1717_CR20","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.3390\/cimb45120633","volume":"45","author":"HF Bahmad","year":"2023","unstructured":"Bahmad HF, Thiravialingam A, Sriganeshan K, et al. Clinical significance of SOX10 expression in human pathology. Curr Issues Mol Biol. 2023;45(12):10131\u201358. https:\/\/doi.org\/10.3390\/cimb45120633.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"1717_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/pcmr.12993","volume":"34","author":"R Campagna","year":"2021","unstructured":"Campagna R, Salvolini E, Pompei V, et al. Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines. Pigment Cell Melanoma Res. 2021;34(6):1039\u201348. https:\/\/doi.org\/10.1111\/pcmr.12993.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1717_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1569897","volume":"15","author":"XX Li","year":"2025","unstructured":"Li XX, Chen JL. TROP2: as a promising target in lung cancer. Front Oncol. 2025;15:1569897. https:\/\/doi.org\/10.3389\/fonc.2025.1569897.","journal-title":"Front Oncol"},{"issue":"12","key":"1717_CR23","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1158\/1078-0432.CCR-22-1305","volume":"29","author":"JM Sperger","year":"2023","unstructured":"Sperger JM, Helzer KT, Stahlfeld CN, et al. Expression and therapeutic targeting of TROP-2 in treatment-resistant prostate cancer. Clin Cancer Res. 2023;29(12):2324\u201335. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1305.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1717_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40364-024-00633-6","volume":"12","author":"Y Hu","year":"2024","unstructured":"Hu Y, Zhu Y, Qi D, et al. Trop2-targeted therapy in breast cancer. Biomark Res. 2024;12(1):82. https:\/\/doi.org\/10.1186\/s40364-024-00633-6.","journal-title":"Biomark Res."},{"issue":"35","key":"1717_CR25","doi-asserted-by":"publisher","first-page":"58642","DOI":"10.18632\/oncotarget.17407","volume":"8","author":"C Avellini","year":"2017","unstructured":"Avellini C, Licini C, Lazzarini R, et al. The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. Oncotarget. 2017;8(35):58642\u201353. https:\/\/doi.org\/10.18632\/oncotarget.17407.","journal-title":"Oncotarget"},{"key":"1717_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1476-4598-9-253","volume":"9","author":"R Cubas","year":"2010","unstructured":"Cubas R, Zhang S, Li M, et al. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer. 2010;9:253. https:\/\/doi.org\/10.1186\/1476-4598-9-253.","journal-title":"Mol Cancer"},{"issue":"7","key":"1717_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.drudis.2013.11.004","volume":"19","author":"HL Perez","year":"2014","unstructured":"Perez HL, Cardarelli PM, Deshpande S, et al. Antibody\u2013drug conjugates: current status and future directions. Drug Discov Today. 2014;19(7):869\u201381. https:\/\/doi.org\/10.1016\/j.drudis.2013.11.004.","journal-title":"Drug Discov Today"},{"key":"1717_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105853","author":"LJ He","year":"2025","unstructured":"He LJ, Wang Y, Curry JL, et al. TROP2 is highly expressed in cutaneous squamous cell carcinomas and a subset of adnexal carcinomas: a potential therapeutic target with TROP2-directed antibody drug conjugates. Hum Pathol. 2025. https:\/\/doi.org\/10.1016\/j.humpath.2025.105853.","journal-title":"Hum Pathol"},{"issue":"11","key":"1717_CR29","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/jcp.24074","volume":"227","author":"M Trerotola","year":"2012","unstructured":"Trerotola M, Li J, Alberti S, et al. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the beta1 integrin-RACK1 axis. J Cell Physiol. 2012;227(11):3670\u20137. https:\/\/doi.org\/10.1002\/jcp.24074.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2353\/ajpath.2010.100149","volume":"177","author":"M Nakatsukasa","year":"2010","unstructured":"Nakatsukasa M, Kawasaki S, Yamasaki K, et al. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol. 2010;177(3):1344\u201355. https:\/\/doi.org\/10.2353\/ajpath.2010.100149.","journal-title":"Am J Pathol"},{"issue":"10","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"e15196","DOI":"10.1111\/exd.15196","volume":"33","author":"K Tanegashima","year":"2024","unstructured":"Tanegashima K, Tanaka Y, Ito T, et al. TROP2 expression and therapeutic implications in cutaneous squamous cell carcinoma: insights from immunohistochemical and functional analysis. Exp Dermatol. 2024;33(10):e15196. https:\/\/doi.org\/10.1111\/exd.15196.","journal-title":"Exp Dermatol"},{"key":"1717_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030607","author":"T Ito","year":"2022","unstructured":"Ito T, Hashimoto H, Tanaka Y, et al. TROP2 expression in sebaceous and sweat gland carcinoma. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11030607.","journal-title":"J Clin Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01717-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:03:11Z","timestamp":1775145791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01717-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01717-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anna Campanati is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Anna Campanati was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sonia Fantone, Daniela Marzioni, Elisa Molinelli, Alessandra Filosa, Gaia Goteri, Roberto Campagna, and Giovanni Tossetta declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Institutional review board approval was waived for this study, as the procedures adopted did not deviate from standard clinical practice. All patients provided written informed consent to have their data collected during routine clinical practice included in this retrospective study, for the retrospective retrieval of anonymized data. The study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments. Data collection and management observed the applicable rules, regulations, and directives concerning patient protection, such as patient privacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}